** Shares of Anteris Technologies AVR.AX fall as much as
7.3% to A$15.80, hitting their lowest since late-Jan
** Medical devices maker says it has completed A$30 mln
($19.81 mln) capital raise via single tranche share placement
** Funds raised will be used for ongoing development of
DurAVR, a trans-catheter heart valve for treating heart
diseases, among others
** Issue price of A$16.00 per share is at a 6.2% discount to
last closing price on July 19
** About 23,900 shares change hands, 2.8 times the 30-day
average volume of 8,586
** Stock had fallen ~11% this year, as of last close
($1 = 1.5147 Australian dollars)
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))